![Pierre Kemula](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Kemula
Director of Finance/CFO at
AGOMAB THERAPEUTICS NV
Net worth: - $ as of 2026-05-30
Profile
Mr. Pierre Kemula is a Chief Financial Officer at CureVac NV and a Chief Financial Officer at CureVac AG. Mr. Kemula was previously employed as a Chief Financial Officer by Pixium Vision SA and a VP-Treasury, Financial Markets & Corporate Finance by Ipsen SA. He received his undergraduate degree from London School of Economics & Political Science.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-17 | 0 ( -.--% ) | - $ | 2026-05-30 |
Pierre Kemula active positions
| Companies | Position | Start |
|---|---|---|
| AGOMAB THERAPEUTICS NV | Director of Finance/CFO | 2024-10-31 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Director of Finance/CFO | 2015-12-31 |
Former positions of Pierre Kemula
| Companies | Position | End |
|---|---|---|
| CUREVAC | Director of Finance/CFO | 2024-10-30 |
| PIXIUM VISION | Director of Finance/CFO | 2017-02-15 |
| IPSEN | Public Communications Contact | 2013-12-31 |
Training of Pierre Kemula
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
33
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pixium Vision SA
 Pixium Vision SA Medical SpecialtiesHealth Technology Operates as a bioelectronics company that develops bionic vision systems | Health Technology |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
- Stock Market
- Insiders
- Pierre Kemula
